Barclays PLC Bristol Myers Squibb CO Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$39.66 - $51.75 $1.54 Million - $2.01 Million	-38,800 Reduced 35.18%	71,500 $3.7 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $1.66 Million - $2.18 Million	-41,200 Reduced 27.19%	110,300 $4.58 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $7.01 Million - $7.94 Million	146,000 Added 2654.55%	151,500 $8.22 Million
Q4 2023 Feb 15, 2024	SELL	$48.48 - $57.85 $1.67 Million - $2 Million	-34,500 Reduced 86.25%	5,500 $282,000
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $2.32 Million - $2.59 Million	40,000 New	40,000 $2.32 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $29.1 Million - $34.5 Million	425,000 New	425,000 $30.6 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $37.1 Million - $43.2 Million	-691,200 Reduced 93.25%	50,000 $3.12 Million
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $490,790 - $556,155	-8,500 Reduced 1.13%	741,200 $46 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $27 Million - $29.9 Million	469,900 Added 167.94%	749,700 $45.2 Million
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $13.8 Million - $16.1 Million	-251,800 Reduced 47.37%	279,800 $16.5 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $8.97 Million - $13 Million	-193,400 Reduced 26.68%	531,600 $29.6 Million
Q4 2019 Feb 10, 2020	SELL	$49.21 - $64.19 $11.2 Million - $14.6 Million	-228,200 Reduced 23.94%	725,000 $46.5 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $6.39 Million - $7.58 Million	149,400 Added 18.59%	953,200 $48.3 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $53.4 Million - $59.1 Million	-1,197,000 Reduced 59.83%	803,800 $36.5 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $69.1 Million - $82.4 Million	1,530,800 Added 325.7%	2,000,800 $95.5 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $1.09 Million - $1.42 Million	-22,400 Reduced 4.55%	470,000 $24.4 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $3.07 Million - $3.46 Million	-55,600 Reduced 10.15%	492,400 $30.6 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $18 Million - $22.4 Million	-356,200 Reduced 39.39%	548,000 $30.3 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $8.96 Million - $10.3 Million	-149,500 Reduced 14.19%	904,200 $57.2 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $33 Million - $36 Million	550,600 Added 109.44%	1,053,700 $64.6 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $27.8 Million - $32.1 Million	503,100	503,100 $32.1 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.32 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.46 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.58 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.58 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account